Johns Hopkins, DuPont create a safer Ebola protection suit

The Johns Hopkins University Center for Bioengineering Innovation and Design in Baltimore has developed an innovative new infectious disease suit with science company DuPont.

Advertisement

The collaboration between Johns Hopkins and DuPont began as a way to meet the humanitarian need identified by the U.S. Agency for International Development during the Ebola outbreak in West Africa.

Together, the research university and the science and engineering company created a garment prototype that features a rear zipper and a “cocoon-style” doffing process that requires far fewer steps than the current suit. The garment aims to reduce the risk of infection to healthcare workers.

“Although this project was triggered by the recent Ebola outbreak, we believe the improved protective suit’s design will be impactful in future infectious disease outbreaks as well,” said Youseph Yazdi, PhD, executive director of Johns Hopkins’ CBID.

 

 

More articles on Ebola:
Portable, rapid DNA test detects Ebola, other pathogens within 5 hours
HHS program advances development of experimental Ebola vaccine
Physicians overestimate ability to assess patients’ Ebola risk, survey finds

Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit

Advertisement

Next Up in Clinical Leadership & Infection Control

Advertisement

Comments are closed.